Per- and polyfluoroalkyl substances (PFAS), as endocrine disruptors, may increase the risk of prostate cancer by interfering with the endocrine system, however, current population-based evidence is still limited, and there are relative few types of PFAS involved. This study aims to investigate ...
The present application provides a method for predicting clinical prognosis for a human subject diagnosed with prostate cancer, comprising: detecting an expression level of a marker
There is no single test for prostate cancer. Urine samples, blood tests and prostate examination are used to help assess the risk of the likelihood of you having prostate cancer alongside the other factors. One of the key tests is the PSA blood test which detects the ...
Down regulation of survivin using LCL-204 can augment the effect of Fas induced apoptosis. LCL-204 can be a potential drug used to augment the effect of AdGFPFasLTET in prostate cancer.Molecular Therapy (2006) 13, S357鈥揝357; doi: 10.1016/j.ymthe.2006.08.1015...